Your browser is no longer supported. Please, upgrade your browser.
Settings
GNVC GenVec, Inc. daily Stock Chart
GNVC [NASD]
GenVec, Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own0.80% Shs Outstand17.25M Perf Week0.40%
Market Cap43.47M Forward P/E- EPS next Y-0.31 Insider Trans3.45% Shs Float15.75M Perf Month13.00%
Income-3.30M PEG- EPS next Q-0.11 Inst Own32.70% Short Float0.24% Perf Quarter11.50%
Sales4.30M P/S10.11 EPS this Y79.20% Inst Trans-8.01% Short Ratio1.33 Perf Half Y-20.50%
Book/sh0.62 P/B4.06 EPS next Y22.50% ROA-23.90% Target Price8.50 Perf Year22.93%
Cash/sh0.64 P/C3.92 EPS next 5Y35.00% ROE-28.10% 52W Range1.61 - 4.67 Perf YTD21.15%
Dividend- P/FCF- EPS past 5Y39.00% ROI-19.50% 52W High-46.04% Beta1.93
Dividend %- Quick Ratio6.60 Sales past 5Y-15.50% Gross Margin- 52W Low56.52% ATR0.22
Employees11 Current Ratio6.60 Sales Q/Q0.00% Oper. Margin-76.70% RSI (14)57.67 Volatility6.72% 10.27%
OptionableNo Debt/Eq0.00 EPS Q/Q-10.00% Profit Margin-76.70% Rel Volume0.15 Prev Close2.50
ShortableYes LT Debt/Eq0.00 EarningsAug 07 AMC Payout- Avg Volume28.54K Price2.52
Recom2.00 SMA206.40% SMA508.99% SMA200-3.49% Volume4,252 Change0.80%
Feb-24-14Initiated HC Wainwright Buy $9
Aug-19-15 01:04PM  GENVEC INC Financials
Aug-10-15 08:13PM  10-Q for GenVec, Inc. at Company Spotlight
Aug-07-15 10:37AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  GenVec Reports Second Quarter 2015 Financial Results PR Newswire
Jun-03-15 08:00AM  GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines PR Newswire
May-28-15 08:00AM  GenVec To Present At The Jefferies Healthcare Conference PR Newswire +7.31%
May-14-15 08:00AM  GenVec Highlights Proprietary Gorilla Vectors At ASGCT Presentation PR Newswire
May-10-15 08:11PM  10-Q for GenVec, Inc. at Company Spotlight
May-08-15 09:48AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  GenVec Reports First Quarter 2015 Financial Results PR Newswire
May-01-15 08:11PM  10-K for GenVec, Inc. at Company Spotlight
Apr-23-15 01:57PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-22-15 08:25AM  Michael Richman Appointed To GenVec Board Of Directors at noodls
08:00AM  Michael Richman Appointed To GenVec Board Of Directors PR Newswire
Apr-21-15 08:29AM  GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology at noodls +5.69%
08:01AM  GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology PR Newswire
Apr-16-15 02:57PM  Bristol-Myers Deal Flags Three Gene-Therapy Picks at Barrons.com
Mar-30-15 09:07AM  GenVec to Release Fourth Quarter and Year-End 2014 Financial Results and Conduct a Conference Call on March 24, 2015 at noodls -5.16%
09:07AM  GenVec To Present At The 27th Annual ROTH Conference at noodls
09:07AM  GenVec Reports Fourth Quarter And 2014 Year-End Financial Results at noodls
09:07AM  GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies at noodls
Mar-24-15 10:00AM  GenVec Inc Earnings Call scheduled for 10:00 am ET today
08:40AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2014 GenVec Inc Earnings Release - Before Market Open
07:00AM  GenVec Reports Fourth Quarter And 2014 Year-End Financial Results PR Newswire
Mar-23-15 07:00AM  GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies PR Newswire
Mar-17-15 08:00AM  GenVec to Release Fourth Quarter and Year-End 2014 Financial Results and Conduct a Conference Call on March 24, 2015 PR Newswire
Mar-02-15 08:00AM  GenVec To Present At The 27th Annual ROTH Conference PR Newswire
Feb-25-15 11:02AM  Video Interview: Doug Swirsky, Chief Executive Officer, GenVec, Inc. [GNVC] GlobeNewswire
Feb-02-15 08:00AM  GenVec To Present At The 17th Annual BIO CEO & Investor Conference PR Newswire +14.45%
Jan-07-15 07:00PM  Lady Gaga at High Volume Drives Hearing-Loss Drug Search: Health at Bloomberg +23.68%
Dec-09-14 04:53PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security
Nov-14-14 07:09PM  10-Q for GenVec, Inc. Company Spotlight
Nov-12-14 09:29AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:18AM  GenVec Reports Third Quarter 2014 Financial Results at noodls
07:55AM  GenVec Reports Third Quarter 2014 Financial Results PR Newswire
Nov-11-14 07:30AM  Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium PR Newswire +8.84%
Nov-05-14 07:15AM  GenVec Achieves Milestone In Hearing And Balance Collaboration PR Newswire
Nov-03-14 04:16PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +7.45%
Oct-31-14 07:30AM  Quinterol Mallette Appointed to GenVec Board Of Directors PR Newswire
Oct-29-14 06:30AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Oct-20-14 09:27AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:00AM  Zola P. Horovitz To Retire From GenVec Board PR Newswire
Aug-12-14 09:42AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  GenVec Reports Second Quarter 2014 Financial Results PR Newswire
Jun-16-14 04:16PM  GENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online
May-12-14 05:10PM  U.S./Canada daily earnings hits & misses May 12 - 1710 ET Reuters
09:31AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:03AM  GenVec sees FY14 cash burn between $5M-$7M at theflyonthewall.com
08:03AM  GenVec reports Q1 EPS (7c), one estimate 4c at theflyonthewall.com
08:00AM  GenVec Reports First Quarter 2014 Financial Results PR Newswire
Mar-28-14 03:02PM  GenVec's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:00AM  GenVec, Inc. Earnings Call scheduled for 10:00 am ET today CCBN
08:55AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:40AM  GenVec Reports Fourth Quarter and 2013 Year-End Financial Results PR Newswire
07:07AM  Q4 2013 GenVec, Inc. Earnings Release - Before Market Open CCBN
Mar-27-14 05:36PM  Why GenVec (GNVC) Stock Is Up In Aftermarket Trading at TheStreet +13.73%
Mar-21-14 08:00AM  GenVec To Release Fourth Quarter And Year-End 2013 Financial Results And Conduct A Conference Call On March 28, 2014 PR Newswire -5.90%
Mar-18-14 05:08PM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Mar-13-14 08:51AM  GenVec Announces $9 Million Registered Direct Offering PR Newswire -5.34%
Mar-03-14 08:00AM  GenVec to Present at 26th Annual ROTH Conference PR Newswire
Feb-26-14 07:31AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Feb-24-14 11:37AM  Coverage initiated on GenVec by HC Wainwright Briefing.com
Feb-13-14 06:15AM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh EDGAR Online
06:00AM  GenVec Achieves Third Milestone In Hearing And Balance Collaboration PR Newswire
Jan-03-14 07:00AM  3 Biotech Stocks Under $10 Triggering Breakouts at TheStreet
Dec-11-13 04:19PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Nov-27-13 09:40AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security EDGAR Online
Nov-12-13 09:52AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online -8.03%
07:50AM  GenVec Reports Third Quarter 2013 Financial Results PR Newswire
Oct-23-13 11:47AM  Online Auction for GenVec, Inc. Hosted by Surplus Solutions LLC and The Branford Group Business Wire
Oct-21-13 04:16PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Oct-07-13 04:15PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Sep-23-13 07:59AM  GenVec announces dismissal of class actoin lawsuit theflyonthewall.com +35.37%
07:59AM  InPlay: GenVec announces dismissal of class action lawsuit Briefing.com
07:58AM  GenVec Announces Dismissal Of Class Action Lawsuit PR Newswire
Sep-19-13 04:46PM  GENVEC INC Files SEC form 8-K, Shareholder Director Nominations EDGAR Online -9.68%
Sep-13-13 06:02PM  Nasdaq stocks posting largest volume increases AP +22.68%
Sep-05-13 04:42PM  GENVEC INC Files SEC form 8-K, Other Events, Regulation FD Disclosure EDGAR Online -10.42%
Sep-04-13 08:30AM  GenVec Board Restructures Operations and Withdraws Plan of Dissolution PR Newswire +77.78%
Aug-13-13 04:07PM  GENVEC INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-08-13 05:27PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Jul-30-13 09:52AM  GENVEC INC Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
Jun-28-13 09:49AM  GENVEC INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities EDGAR Online
Jun-25-13 09:46AM  GENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf EDGAR Online
Jun-24-13 09:51AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
May-28-13 01:30AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
May-10-13 09:10AM  GENVEC INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Apr-26-13 02:22AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Mar-27-13 06:00PM  UK scientists develop safer foot-and-mouth vaccine at Reuters
Mar-22-13 05:51PM  GenVec Q4 Net Loss Deepens at Motley Fool
01:21PM  GenVec CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
10:00AM  GenVec, Inc. Earnings Call scheduled for 10:00 am ET today CCBN
07:59AM  GenVec sees FY13 cash burn to be between $8M-$9M theflyonthewall.com
07:58AM  GenVec Reports Fourth Quarter And 2012 Year-End Financial Results PR Newswire
07:07AM  Q4 2012 GenVec, Inc. Earnings Release - Before Market Open CCBN
02:23AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on using its adenovector gene delivery platform to develop a pipeline of therapeutics and vaccines in the United States. Its vaccine against foot and mouth disease in cattle has been approved. The company's lead product candidate, CGF166 is in Phase 1/2 clinical study for the treatment of hearing loss and balance disorders. Its product pipeline also includes GV2311, a vaccine for respiratory syncytial virus; and GV2207, a herpes simplex virus-2 immunotherapeutic. The company is also developing vaccines against other infectious diseases, such as Enterovirus D68 (EV-D68) and malaria. GenVec, Inc. has partnership agreements with Novartis AG, Laboratory of Malaria Immunology and Vaccinology, Washington University, and Merial Limited, as well as with TheraBiologics, Inc. to develop cancer therapeutics. The company was founded in 1992 and is based in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brough Douglas EChief Scientific OfficerAug 11Buy2.344,60010,785136,683Aug 11 04:25 PM